Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways.
Gökmen-Polar Y, Neelamraju Y, Goswami CP, Gu Y, Gu X, Nallamothu G, Vieth E, Janga SC, Ryan M, Badve SS.
Gökmen-Polar Y, et al. Among authors: gu x, gu y.
EMBO Rep. 2019 Feb;20(2):e46078. doi: 10.15252/embr.201846078. Epub 2019 Jan 21.
EMBO Rep. 2019.
PMID: 30665944
Free PMC article.